Unternehmen
NETHERLANDS CENTER FOR THE CLINICAL ADVANCEMENT OF STEM CELL & GENE THERAPIES BV
NETHERLANDS CENTER FOR THE CLINICAL ADVANCEMENT OF STEM CELL & GENE THERAPIES BV – Unternehmen mit Aktivitäten in Forschung und Innovation.
Weiter entdecken
Ähnliche Beiträge
Projekt
→
The Gene Therapy CoE at the Center of Portugal
The main goal of the present project is the creation of a Gene Therapy research & innovation hub rooted in a Center of Excellence… Beitrag ansehen →
Projekt
→
Exploiting ex vivo expansion and deep multiomics profiling to bring novel, efficient and safer hematopoietic stem cell gene therapies to clinical application
Hematopoietic stem cells (HSC) are an elusive cell type, whose presence can only be inferred retrospectively, from the outcome of… Beitrag ansehen →
Projekt
→
Next-generation models and genetic therapies for rare neuromuscular diseases
Muscular dystrophies are severe genetic disorders characterised by muscle wasting, impaired mobility and premature death, which t… Beitrag ansehen →
Projekt
→
Clinical portfolio strategy for regenerative muscle stem cell therapies
MyoPax is a women founded company with locations in Germany and in Denmark. Myopax uses a proprietary, patented, first-in-class s… Beitrag ansehen →
Projekt
→
The GEne Therapy INnovation Training Network
Gene therapy has transitioned from a distant hope to reality. To date 3 rAAV gene therapies are approved in the EU, >30 phase III… Beitrag ansehen →
Projekt
→
Transcription Factor-mediated Induction of Cardiomoycyte proliferation.
Heart failure is a major global public health problem affecting over 23 million patients worldwide. There are no effective therap… Beitrag ansehen →
Passend zu diesem Beitrag
Forschungsprojekte
- Biointelligent Production Sensor to Measure Viral Activity We aim to transform virus biomanufacturing processes and enable new quality control strategies by a continuou… →
- PEN photoporation for the genetic engineering of therapeutic mesenchymal stromal cells and T cells Adoptive cell therapy has emerged as a promising strategy to treat cancer. It relies on patient-derived cells… →